Roles of CRTH2+ CD4+ T cells in immunoglobulin G4-related lacrimal gland enlargement

International Archives of Allergy and Immunology

Volumn 158, Issue SUPPL. 1, 2012, Pages 42-46

  Saito, Yukari ^b   Kagami, Shin Ichiro ^a,b   Kawashima, Saki ^b   Takahashi, Kentaro ^a,b   Ikeda, Kei ^a,b   Hirose, Koichi ^a,b   Oshitari, Toshiyuki ^b   Yamamoto, Shuichi ^b   Okamoto, Yoshitaka ^b   Nakajima, Hiroshi ^a,b  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

CRTH2+ CD4+ T cells; Immunoglobulin G4; Lacrimal gland enlargement

Indexed keywords

BUDESONIDE; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; FLUTICASONE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR GATA 3;

ADULT; AGED; ALLERGIC ASTHMA; AUTOIMMUNE PANCREATITIS; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; LACRIMAL GLAND DISEASE; LACRIMAL GLAND ENLARGEMENT; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROPERITONEAL FIBROSIS; TH2 CELL;

ADULT; AGED; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN G; LACRIMAL APPARATUS DISEASES; MALE; MIDDLE AGED; RECEPTORS, CCR4; RECEPTORS, CXCR3; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN;

EID: 84861586548     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000337761     Document Type: Conference Paper

References (20)

1. Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T: IgG4-related disease: historical overview and pathology of hema-tological disorders. Pat hol Int 2010; 60: 247-258.
2. Khosroshahi A, Stone JH: A clinical overview of IgG4-related systemic disease. Curr Opin R heumatol 2011; 23: 57-66.
3. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K: High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732-738. (Pubitemid 32204991)
4. Ichimura T, Kondo S, Ambo Y, Hirano S, Ohmi M, Okushiba S, Morikawa T, Shimizu M, Katoh H: Primary sclerosing cholangitis associated with autoimmune pancreatitis. Hepatogastroenterology 2002;49:1221-1224.
5. Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, Nakazawa K, Shimojo H, Kiyosawa K: Hydronephrosis associated with ret-roperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359:1403-1404. (Pubitemid 34442382)
6. Takeda S, Haratake J, Kasai T, Takaeda C, Takazakura E: IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant 2004; 19: 474-476. (Pubitemid 38196002)
7. Zen Y, Kitagawa S, Minato H, Kurumaya H, Katayanagi K, Masuda S, Niwa H, Fujimura M, Nakanuma Y: IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005; 36: 710-717. (Pubitemid 41112024)
8. Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Takahashi H, Imai K: Clinical and pathological differences between Mikulicz's disease and Siögren's syndrome. Rheumatolog y 2004; 44: 227-234.
9. Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, Nakanuma Y: Th2 and regulatory immune reactions are increased in immunoglobulin IgG4-related sclerosing pancreatitis and cholangitis. Hepatology 2007; 45: 1538-154 6. (Pubitemid 46918338)
10. Miyake K, Moriyama M, Aizawa K, Nagano S, Inoue Y, Sadanaga A, Nakashima H, Na-kamura S: Peripheral CD4+ T cells showing a Th2 phenotype in a patient with Mikulicz's disease associated with lymphadenopathy and pleural effusion. Mod Rheumatol 2008; 18: 86-90.
11. Kanari H, Kagami S, Kashiwakuma D, Oya A, Furuta S, Ikeda K, Suto A, Suzuki K, Hi-rose K, Watanabe N, Okamoto Y, Yamamoto S, Iwamoto I, Nakajima H: Role of Th2 cells in IgG4-related lacrimal gland enlargement. Int Arch Allergy Immunol 2010; 152:s47-s53.
12. Pettipher R, Hansel TT, Armer R: Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov 2007; 6:313-325. (Pubitemid 46505882)
13. Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG, Pettipher R: Pros-taglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 2005; 175:6531-6536. (Pubitemid 41598895)
14. De Fanis U, Mori F, Kurnat RJ, Lee WK, Bova M, Adkinson NF, Casolaro V: GATA-3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood 2007; 10 9: 4343-4350. (Pubitemid 46743402)
15. Cosmi L, Annunziato F, Galli MIG, Maggi RME, Nagata K, Romagnani S: CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 cyto-toxic cells in health and disease. Eur J Immunol 2000; 30:2972-2979.
16. Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, Yoshie O, Abe H, Tada K, Nakamura M, Sugamura K, Takano S: Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 1999; 162:1278-1286. (Pubitemid 29306996)
17. Xue L, Barrow A, Pettipher R: Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway. J Immunol 2009; 18 2: 7580-7586.
18. Khosroshahi A, Stone JH: Treatment approaches to IgG4-related systemic disease. Curr Opin R heumatol 2011; 23: 57-66.
19. Kostenis E, Ulven T: Emerging roles of DP and CRTH2 in allergic inflammation. Trends Mol Med 2006; 12:148-158.
20. Barnes N, Pavord I, Chuchalin A, Bell J, Hunter M, Lewis T, Parker D, Payton M, Collins LP, Pettipher R, Steiner J, Perkins CM: A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma. Clin Exp Allergy 2012; 42:38-48.